{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:29:01Z","timestamp":1778632141271,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jpba.2011.10.021","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T10:09:21Z","timestamp":1319623761000},"page":"138-150","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC\/MS\/MS"],"prefix":"10.1016","volume":"59","author":[{"given":"Paul D.","family":"Rainville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.10.021_bib0005","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4155\/bio.10.85","article-title":"Regulatory observances in bioanalytical determinations","volume":"2","author":"Viswanathan","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2011.10.021_bib0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4155\/bio.09.108","article-title":"Incurred sample reproducibility: views and recommendations by the European bioanalysis forum","volume":"1","author":"Timmerman","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2011.10.021_bib0015","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1208\/aapsj0901004","article-title":"Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays","volume":"9","author":"Viswanathan","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2011.10.021_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/rcm.3465","article-title":"Sub one minute inhibition assays for the major p450 enzymes utilizing ultra-performance liquid chromatography\/tandem mass spectrometry","volume":"22","author":"Rainville","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/138920006777697927","article-title":"LC\u2013MS development strategies for quantitative bioanalysis","volume":"7","author":"Jemal","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2011.10.021_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-322-0_22","article-title":"Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"579","author":"Bielawski","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2011.10.021_bib0035","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/rcm.4121","volume":"23","author":"Xia","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0040","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S1359-6446(05)03620-2","article-title":"Principles and applications of LC\u2013MS in new drug discovery","volume":"10","author":"Korfmacher","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2011.10.021_bib0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4155\/bio.09.18","article-title":"Pharmacokinetic applications of microdevices and microsampling techniques","volume":"1","author":"Musteata","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2011.10.021_bib0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2011.10.021_bib0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jchromb.2005.12.050","article-title":"Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin","volume":"832","author":"Aburuz","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0060","doi-asserted-by":"crossref","first-page":"460A","DOI":"10.1021\/ac053516f","article-title":"Advancing LC performance with smaller particles and higher pressure","volume":"77","author":"Mazzeo","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2011.10.021_bib0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jpba.2006.12.012","article-title":"New perspectives in bio-analytical techniques for preclinical characterization of a drug candidate: UPLC-MS\/MS in in vitro metabolism and pharmacokinetic studies","volume":"44","author":"Pedraglio","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.10.021_bib0070","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jpba.2005.06.020","article-title":"Orthogonal extraction\/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25pg\/mL","volume":"40","author":"Shen","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.10.021_bib0075","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jchromb.2009.01.003","article-title":"Validation of bioanalytical LC-MS\/MS assays: evaluation of matrix effects","volume":"877","author":"Van Eeckhaut","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0080","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Maturszowski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2011.10.021_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jchromb.2007.06.010","article-title":"Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC\/MS\/MS at low pg\/ml concentration levels","volume":"856","author":"Capka","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0090","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.jchromb.2009.09.026","article-title":"Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry","volume":"877","author":"Bucelli","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0095","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1016\/j.jchromb.2009.10.012","article-title":"Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain","volume":"877","author":"Miller","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0100","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1002\/rcm.4275","article-title":"Screening strategy for the rapid detection of in vitro generated glutathione conjugates using high-performance liquid chromatography and low-resolution mass spectrometry in combination with LightSight software for data processing","volume":"23","author":"Ramirez-Moline","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/rcm.1001","article-title":"Microcapillary liquid chromatography\/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection","volume":"17","author":"Tomlinson","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2007.11.048","article-title":"Analysis of basic compounds by reversed-phase liquid chromatography\u2013electrospray mass spectrometry in high-pH mobile phases","volume":"1179","author":"Peng","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2011.10.021_bib0115","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.jchromb.2009.08.049","article-title":"Screening ionisation and chromatography conditions for quantitative LC\/MS methods","volume":"877","author":"Sillen","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/dta.90","article-title":"Development of a high sensitivity bioanalytical method for alprazolam using ultra-performance liquid chromatography\/tandem mass spectrometry","volume":"2","author":"Mather","year":"2010","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2011.10.021_bib0125","unstructured":"Waters Corporation, Waters Technical Bulletin for XTerra Columns, 1999, WD164."},{"key":"10.1016\/j.jpba.2011.10.021_bib0130","unstructured":"Waters Corporation, Waters XBridge Columns Brochure, 2008. Available at http:\/\/www.waters.com\/waters\/library.htm?cid=511436&lid=10057202."},{"key":"10.1016\/j.jpba.2011.10.021_bib0135","unstructured":"FDA Guidance on Bioanalytical Method Validation, 2001. Available at http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070107.pdf."},{"key":"10.1016\/j.jpba.2011.10.021_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2006.02.011","article-title":"Liquid chromatography-mass spectrometry\/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma","volume":"833","author":"Little","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2011.10.021_bib0145","unstructured":"P. Bennett, H. Liang, Tandem Capabilities Publications. Available at http:\/\/www.tandemlabs.com\/documents\/PatrickASMSPaper.pdf."},{"key":"10.1016\/j.jpba.2011.10.021_bib0150","unstructured":"M. Meng, P. Bennett, Tandem Capabilities Publications. Available at http:\/\/www.tandemlabs.com\/documents\/MinASMSPaper.pdf."},{"key":"10.1016\/j.jpba.2011.10.021_bib0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/pr060611b","article-title":"Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics","volume":"6","author":"Rainville","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2011.10.021_bib0160","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/rcm.1923","article-title":"Positive electrospray liquid chromatography\/mass spectrometry using high-pH gradients: a way to combine selectivity and sensitivity for a large variety of drugs","volume":"19","author":"Delatour","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0165","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/rcm.1290091511","article-title":"Effects of solvent composition on molecular ion response in electrospray mass spectrometry: investigation of the ionization process","volume":"9","author":"Zhou","year":"1995","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.10.021_bib0170","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/rcm.329","article-title":"Direct analysis of pharmaceutical compounds in human plasma with chromatographic resolution using an alkyl-bonded silica rod column","volume":"15","author":"Plumb","year":"2001","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511005978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511005978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T04:20:17Z","timestamp":1713068417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511005978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":34,"alternative-id":["S0731708511005978"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.10.021","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}